PROCEPT BioRobotics Corporation (PRCT) Misses Q3 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.01 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $16.79 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2022 revenue of $72.5 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Truist Securities Downgrades Procept BioRobotics Corp (PRCT) to Hold
• ​Trump said he was unaware of his earnings from crypto
• Constellation Brands (STZ) Tops Q1 EPS by 18c